Document Detail

Myasthenia gravis (MG) treatment with immunoadsorbent columns.
MedLine Citation:
PMID:  1751675     Owner:  NLM     Status:  MEDLINE    
We performed ten plasma perfusion (PP) treatments on eight patients affected by Myasthenia Gravis (MG) with high serum levels of autoantibodies against acetylcholine receptors (anti AChR-AB), and one PP treatment on a patient with MG of probable genetic origin and without specific antibodies. All patients (Osserman group III-IV) had undergone thymectomy and immunosuppressive therapy. Each patient received a treatment cycle of six PP sessions. Clinical conditions were assessed before and after the treatment with evaluation of muscular strength, ventilatory function, and electromyographic testing. Immunologic markers were tested before and after each PP. The patient without specific antibodies showed no improvement with PP and was excluded from our study. All the other patients showed continued improvement, with increased muscle strength and improved respiratory function. Four patients (follow-up 16-24 months) still maintain the clinical improvement; two, unexpectedly relapsed 11-12 months after PP, received a new treatment successfully (follow-up 9-10 month).
G Splendiani; S Passalacqua; G Barbera; A Sturniolo; S Costanzi; E Bartoccioni; C U Casciani
Related Documents :
25388645 - Association of abnormal lipid spectrum with the disease activity of takayasu arteritis.
20551455 - Alarm features and age for predicting upper gastrointestinal malignancy in chinese pati...
3946445 - Monoclonal hypergammaglobulinemia without malignant transformation in angioimmunoblasti...
2112245 - Long term treatment of myasthenia gravis with azathioprine.
16004175 - Actinomycosis esophagitis in a patient with persistent dysphagia.
20447065 - D3-growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology     Volume:  19     ISSN:  1055-7172     ISO Abbreviation:  Biomater Artif Cells Immobilization Biotechnol     Publication Date:  1991  
Date Detail:
Created Date:  1992-01-30     Completed Date:  1992-01-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9111988     Medline TA:  Biomater Artif Cells Immobilization Biotechnol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  255-65     Citation Subset:  IM    
2d Università Tor Vergata, C.I. Columbus, Roma.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Follow-Up Studies
Hemoperfusion / adverse effects,  methods*
Myasthenia Gravis / blood,  therapy*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Self-regulated delivery of insulin from microcapsules.
Next Document:  Immunoadsorption with PH-350: as a beneficial therapy for acute Guillain-Barre syndrome.